Department of Urology, MD Anderson Cancer Center, Houston, TX 77030, USA.
Int J Urol. 2012 Sep;19(9):861-6. doi: 10.1111/j.1442-2042.2012.03034.x. Epub 2012 May 9.
To report the intermediate outcomes of a transcorporally placed artificial urinary sphincter.
Medical records of 16 consecutive patients treated with transcorporal placement of artificial urinary sphincter from March 2003 to October 2008 were reviewed. The indications for surgery, operative logs, postoperative evaluations, complication rate and postoperative questionnaire assessment utilizing the International Continence Society short form for men were analyzed.
Eight patients each underwent primary transcorporal cuff placement and revision surgery. Complete data for analysis were available in 15 patients at a median follow up of 45 months (range 23-91 months). The success rate (defined as use of 0-1 pads per day) was 80% (12/15 patients). Average voiding score was 2/20 (standard deviation 1.88), average irritative score was 3/24 (standard deviation 4.92) and the mean Quality-of-Life score was 0.66 (standard deviation 1.04).
Transcorporal placement of an artificial urinary sphincter is both safe and efficacious in patients with a small caliber or atrophic urethra, either as a primary or salvage procedure. Efficacy and level of satisfaction in this subset of patients is equivalent to those undergoing traditional artificial urinary sphincter cuff placement.
报告经体腔置入人工尿道括约肌的中期结果。
回顾了 2003 年 3 月至 2008 年 10 月期间接受经体腔置入人工尿道括约肌治疗的 16 例连续患者的病历。分析了手术适应证、手术记录、术后评估、并发症发生率以及术后利用国际尿控协会男性简短问卷进行的评估。
8 例患者分别接受了初次经体腔袖套放置和翻修手术。在中位随访 45 个月（范围 23-91 个月）时，15 例患者中有 15 例可获得完整数据用于分析。成功率（定义为每天使用 0-1 个尿垫）为 80%（12/15 例患者）。平均排尿评分 2/20（标准差 1.88），平均刺激性评分 3/24（标准差 4.92），平均生活质量评分 0.66（标准差 1.04）。
对于尿道口径较小或萎缩的患者，无论是初次手术还是挽救性手术，经体腔置入人工尿道括约肌既安全又有效。在这组患者中，疗效和满意度与接受传统人工尿道括约肌袖套放置的患者相当。
